Stereotactic Body Radiation Therapy for Low, Intermediate, and High-risk Prostate Cancer: Disease Control and Quality of Life

被引：10
|
作者：
Katz, A. J. [1 ]
Santoro, M. [1 ]
DiBlasio, F. [2 ]
Ashley, R. [3 ]
机构：
[1] Flushing Radiat, Flushing, NY USA
[2] Mt Sinai Hosp, Huntington, NY USA
[3] Long Isl Jewish N Shore Hosp, New Hyde Pk, NY USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2011.06.204
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S100 / S100
页数：1
相关论文
共 50 条
  • [21] Current use of stereotactic body radiation therapy for low and intermediate risk prostate cancer: A National Cancer Database Analysis
    Timothy D. Malouff
    William C. Stross
    Danushka S. Seneviratne
    Mark R. Waddle
    Byron C. May
    Steven J. Buskirk
    Katherine S. Tzou
    Prostate Cancer and Prostatic Diseases, 2020, 23 : 349 - 355
  • [22] Management of Isolated Local Failures Following Stereotactic Body Radiation Therapy for Low to Intermediate Risk Prostate Cancer
    Aghdam, Nima
    Pepin, Abigail N.
    Creswell, Michael
    Hsieh, Kristin
    Smith, Clayton
    Drescher, Nicolette
    Danner, Malika
    Ayoob, Marilyn
    Yung, Thomas
    Lei, Siyuan
    Kumar, Deepak
    Collins, Brian Timothy
    Lischalk, Jonathan W.
    Krishnan, Pranay
    Suy, Simeng
    Lynch, John
    Bandi, Guarav
    Hankins, Ryan Andrew
    Collins, Sean P.
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [23] Hypofractionated stereotactic body radiation therapy in low-risk prostate cancer
    Kim, H. J.
    Kim, W. C.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S90 - S91
  • [24] Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer
    Anwar, Mekhail
    Weinberg, Vivian V.
    Seymour, Zachary
    Hsu, I. Joe
    Roach, Mack, III
    Gottschalk, Alex R.
    RADIATION ONCOLOGY, 2016, 11
  • [25] Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer
    Mekhail Anwar
    Vivian Weinberg
    Zachary Seymour
    I. Joe Hsu
    Mack Roach
    Alex R. Gottschalk
    Radiation Oncology, 11
  • [26] Prostate-Specific Antigen Kinetics After Hypofractionated Stereotactic Body Radiation Therapy Boost and Whole-Pelvic Radiation Therapy for Intermediate- and High-Risk Prostate Cancer
    Kim, H. J.
    Kim, W. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E286 - E286
  • [27] Stereotactic Body Radiation Therapy for Unfavorable Intermediate-and High-Risk Prostate Cancer: 3-Year Outcomes of a Phase II Trial
    Macias-Hernandez, V. A.
    Barrera-Mellado, I.
    Marti, C.
    Pont, A.
    Fernandez-Lara, A.
    Soria, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S105 - S106
  • [28] Management of isolated local failures following stereotactic body radiation therapy for low to intermediate risk prostate cancer.
    Drescher, Nicolette
    Aghdam, Nima
    Danner, Malika
    Ayoob, Marilyn
    Yung, Thomas M.
    Lei, Siyuan
    Collins, Brian Timothy
    Lischalk, Jonathan
    Dritschilo, Anatoly
    Suy, Simeng
    Kumar, Deepak
    Lynch, John J.
    Collins, Sean P.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [29] STEREOTACTIC BODY RADIATION THERAPY IN LOW- AND INTERMEDIATE-RISK PROSTATE CANCER: RESULTS OF PHASE II STUDY
    Franzese, Ciro
    D'agostino, Giuseppe Roberto
    Liardo, Rocco Luca Emanuele
    Reggiori, Giacomo
    Navarria, Pierina
    Cristina, Iftode
    De Rose, Fiorenza
    Franceschini, Davide
    Tozzi, Angelo
    Comito, Tiziana
    Ascolese, Anna Maria
    Tomatis, Stefano
    Cozzi, Luca
    Scorsetti, Marta
    ANTICANCER RESEARCH, 2016, 36 (05) : 2545 - 2545
  • [30] High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiation
    Lischalk, Jonathan W.
    Akerman, Meredith
    Repka, Michael C.
    Sanchez, Astrid
    Mendez, Christopher
    Santos, Vianca F.
    Carpenter, Todd
    Wise, David
    Corcoran, Anthony
    Lepor, Herbert
    Katz, Aaron
    Haas, Jonathan A.
    FRONTIERS IN ONCOLOGY, 2024, 14
12345